The 2nd COMy Congress will bring to the forefront the latest and most controversial data and information in the field of Multiple Myeloma, providing a unique opportunity for world class leaders in the field to debate vital and contentious issues in Myeloma.

This thought-provoking academic dialogue will address the most challenging current clinical and therapeutic questions.

The unique format of the COMy program provides ample time for discussion following each debate and participants are encouraged to take a pro-active role in this academic dialogue.

These stimulating debates will provide clinicians with state-of-the-art recommendations regarding patient care.

We invite you to join us for this exciting and unique event in the beautiful and vibrant city of Paris.

Highlighted Topics

• Myeloma in 2016: The search for a cure?
• Biology and diagnosis
• Treatment of younger myeloma patients
• Maintenance and consolidation after transplantation
• Clinical cases discussions: Young myeloma case, elderly myeloma case, relapsed myeloma case, a high risk myeloma case
• Treatment of elderly myeloma patients
• Treatment of relapsed myeloma
• Bone disease
• Management of side effects
• New drugs development
• Waldenstrom disease